[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335826-105":59,"doc-detail-335826-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","prognostic-impact-of-neurocognitive-disorders-in-older-patients-with-cancer-the-elcapa-prospective-cohort-study","Prognostic impact of neurocognitive disorders in older patients with cancer - the ELCAPA prospective cohort study","","Objective: To assess the prognostic value of neurocognitive disorder (NCD) for 12-month overall mortality in patients aged 70 or more with a solid cancer. Design: prospective, observational, multicenter cohort. Setting and participants: data from the ELCAPA longitudinal multicenter cohort of older adults referred for geriatric assessment before a new cancer treatment modality (Jan 31, 2007–Dec 29, 2017). Baseline NCD was defined in four classes using MMSE, memory complaint, and IADL score. Statistical methods compared baseline features by NCD class and estimated survival using univariable and multivariable 12-month analyses with adjustment for treatment strategy (curative, palliative, exclusive supportive care). Results: 2784 solid-cancer patients were included; major NCD was an independent prognostic factor for 12-month overall mortality.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-impact-of-neurocognitive-disorders-in-older-patients-with-cancer-the-elcapa-prospective-cohort-study/335826/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-impact-of-neurocognitive-disorders-in-older-patients-with-cancer-the-elcapa-prospective-cohort-study/335826.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How was neurocognitive disorder (NCD) defined at baseline in this study?","Question",{"text":113,"@type":114},"Baseline NCD was categorized into four classes (no, mild, moderate, major) using MMSE score, memory complaint, and IADL score.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What was the primary prognostic outcome and follow-up period?",{"text":118,"@type":114},"The study evaluated 12-month overall mortality as the key prognostic outcome.",{"name":120,"@type":111,"acceptedAnswer":121},"Did NCD severity remain predictive after accounting for the treatment strategy?",{"text":122,"@type":114},"Yes. Additional adjustment for treatment strategy did not substantially change the strength of the association between major NCD and 12-month overall mortality.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335826,1790645784,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":46,"preview_page_count":4},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","The Journal of Nutrition, Health and Aging 28 (2024) 100215  \nContents lists available at ScienceDirect  \nThe Journal of Nutrition, Health and Aging  \njournal [homepage:](homepage: www. elsevier. com/locate/j nha)[ www. elsevier. com/locate/j nha](homepage: www. elsevier. com/locate/j nha)  \n| Original Article |  |  |  |\n| --- | --- | --- | --- |\n| Prognostic impact of neurocognitive disorders in older patients with cancer: the ELCAPA prospective cohort study |  |  | |\n| Catherine Conti a, b, *, Elena Paillaud a,b, Marie Laurent b, c, Johanne Poisson a, d, Pascaline Boudou-Rouquette e, Maxime Frelautf, Pierre Gay a, Johanna Canovas a, Philippe Caillet a, b, Soraya Mebarki a, Amaury Broussierb, g, Florence Canouï-Poitrineb, h\u003Cbr>a AP-HP, Paris Cancer Institute CARPEM, Hôpital Européen Georges Pompidou, Department of Geriatrics, F-75015 Paris, France b Université Paris-Est, Inserm, 7376-IMRB, F-94000 Créteil, France\u003Cbr>c AP-HP, Hopital Henri-Mondor, Department of Internal Medicine and Geriatrics, F-94010 Creteil, France d Université Paris-Cité, Center for Research on Inflammation, Inserm U1149, F-75018 Paris, France e AP-HP, Hôpital Cochin – Port-Royal, Department of Oncology, F-75014 Paris, France\u003Cbr>f Gustave Roussy Cancer Campus, F-94076 Villejuif, France\u003Cbr>g AP-HP, Hôpitaux Henri-Mondor/Emile Roux, Department of Geriatrics, F-94456 Limeil-Brevannes, F-94000 Créteil, France hAP-HP, Hopital Henri-Mondor, Public Health Departement, F-94010 Creteil, France |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords: Neurocognitive disorder Older adult\u003Cbr>Cancer\u003Cbr>Prognostic value Mortality |  | Objective: To assess the prognostic value ofneurocognitive disorder(NCD)for12month-overall mortality inpatients aged 70 or more with a solid cancer.\u003Cbr>Design: prospective, observational, multicenter cohort.\u003Cbr>Settingandparticipants: We analyzed data from theELCAPA longitudinal multicenter observational cohort ofpatients aged 70 or over, referred for a geriatric assessment (GA) before a new cancer treatment modality between January 31st, 2007, and December 29th, 2017. We defined the baseline NCD in four classes: no NCD, mild NCD, moderate NCD, and major NCD, based on the Mini-Mental State Examination (MMSE) score, memory complaint, and the Instrumental Activities of Daily Living (IADL) score.\u003Cbr>Statistical methods: We compared the baseline characteristics of patients according to NCD classes, globally and by pairs (with Bonferroni’ correction). Prognosis value of NCD classes were analysed by using univariable and then multivariable 12 month survival analysis with age as time-variable and with and without adjustement for the treatment strategy (curative, palliative or exclusive supportive care).\u003Cbr>Results: 2784patientswith solid-cancer were included, with a median[interquartile range]age of82[78;86].36%of the patients were free of NCD, 34% had a mild NCD, 17% had a moderate NCD, and 13% had a major NCD. We identified the following independent prognostic factors for 12 month-overall mortality: NCD (adjusted hazard ratio (aHR) [95% confidence interval (CI)] for a major NCD = 1.54 [1.19–1.98](p \u003C 0.001), type of cancer, metastatic status, inpatient consultation, poor general health(assessed asthe level offatigue and Eastern Cooperative Oncology Group performance status [ECOG-PS]), greater weight loss, palliative treatment, and exclusive supportive care. Additional adjustment for the treatment strategy did not greatly change the strength of the association of a major NCD with 12 month-overall mortality (HR [95%CI] = 1.78 [1.39–2.29](p \u003C 0.001).\u003Cbr>Conclusion: Our results suggest that the presence of a major NCD has direct prognostic value (independently of other geriatric factors, the type of cancer and the treatment strategy) in older patients with a solid cancer.\u003Cbr>© 2024 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher. This is an open access article under the CC BY license ([http://creativecommon","cbCaiuLrJ37XhZGw","https://ap.wps.com/l/cbCaiuLrJ37XhZGw","pdf",1456654,"English","# Introduction\n## Prognostic assessment challenges in older adults with cancer\n# Methods\n## Study design and cohort source (ELCAPA)\n## Definition of baseline NCD classes\n## Statistical analyses and treatment-strategy adjustment\n# Results\n## Distribution of NCD severity classes\n## Independent prognostic factors for 12-month mortality\n## Effect of adjusting for treatment strategy\n# Conclusion","[{\"question\":\"How was neurocognitive disorder (NCD) defined at baseline in this study?\",\"answer\":\"Baseline NCD was categorized into four classes (no, mild, moderate, major) using MMSE score, memory complaint, and IADL score.\"},{\"question\":\"What was the primary prognostic outcome and follow-up period?\",\"answer\":\"The study evaluated 12-month overall mortality as the key prognostic outcome.\"},{\"question\":\"Did NCD severity remain predictive after accounting for the treatment strategy?\",\"answer\":\"Yes. Additional adjustment for treatment strategy did not substantially change the strength of the association between major NCD and 12-month overall mortality.\"}]","Prognostic impact of neurocognitive disorders in older patients with cancer - the ELCAPA prospective cohort study | PDF",1790012438]